Spinal needles Market Share

Global Spinal Needles Market Overview

Spinal Needles Market Size was valued at USD 0.30 Billion in 2023. The Global Spinal Needles industry is projected to grow from USD 0.33 Billion in 2024 to USD 0.59 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.91% during the forecast period (2024 - 2032).

The rising geriatric population prone to spinal disorders, the increasing prevalence of spinal stenosis and neurological disorders is driving the market growth.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Spinal Needles Market Trends

• Increasing prevalence of spinal stenosis and neurological disorder

Spinal stenosis is a medical condition characterized by the compression of nerve roots by several pathological factors related to cord dysfunction elicited by a combination of mechanical compression and degenerative instability. The symptom of spinal stenosis includes weakness, pain, and numbness. A research article published in the American Institute of Minimally Invasive Surgery (AIMIS) in 2018 describes that approximately 250,000-500,000 suffer from spinal stenosis representing 1 per 1000 persons older than 65 years and about 5 of every 1,000 persons older than 50 years in America. This rising aging population suffering from spinal stenosis clearly demands an effective surgical intervention. Thus, this factor boosts the market growth of spinal needles.

Furthermore, an increasing number of neurological disorders also act as a driving factor for market growth. According to the data published in Front Range Spine and Neurosurgery in 2018, more than 600 neurological conditions have been identified, affecting hundreds of millions globally.

Spinal Needles Market Segment Insights

Spinal Needles Type Insights

The Spinal Needles Market segmentation, based on type, includes pencil-point needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is to hold the majority share in 2021 in the Spinal Needles Market revenue. This is due to the collective efforts of the organization/ universities to effectively deploy it. In addition, the role of CTMS in the campus-wide adoption was to support multi-dimensional investigations, cancer trials, and pharmaceutical research. Leading companies in the pharmaceutical industry use enterprise-wide types like impact CTMS.

January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

Spinal Needles Application Insights

The Spinal Needles Market segmentation is based on an application that includes, therapeutic, diagnostic. The therapeutic segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. This is because the spinal needles are used to inject analgesia and/or anesthetic directly into the cerebrospinal fluid. Spinal needles enter the cerebral spinal fluid (CSF) through the membranes surrounding the spinal cord. Some of the notable products in the spinal needle market include Sprotte spinal needle by Pajunk (Germany), Whitacre-Pencil point spinal anesthesia needle by Becton, Dickinson and Company (US), and Quincke spinal needle by Vygon SA (France). The utility of spinal needles is increasing with the recently increasing number of clinical investigations.

Figure 2 SPINAL NEEDLES MARKET, BY TYPE, 2021 & 2032 (USD BILLION)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Spinal Needles End User Insights

The Spinal Needles Market segmentation is based on end-user that includes hospitals & clinics, diagnostic centers, research laboratories, and others. The hospitals & clinics segment has dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. This is due to the increasing number of patients getting monitored with spinal disorders. Since advanced and complete treatments are available in the hospital, patients normally prefer to get treated at the hospital. A spinal anesthetic is used for lower abdominal, pelvic, rectal, or lower extremity surgery. Clinics are also medical care centers that provide care for patients suffering from various neurodegenerative diseases.

December 2020: Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

Spinal Needles Regional Insights

By Region, the study segments the market into Americas, Europe, Asia-Pacific, and the Middle East & Africa. The America spinal needles market is expected to account for USD 0.09 billion in 2021 and is expected to exhibit a CAGR over 6.50% during the study period. This is attributed to the rising number of patients suffering from spinal disorders. For instance, in September 2019, B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution which works in real-time for regional anaesthesia processes.  This works in line with Philip’s ultrasound system, making anaesthesia processes safer and more accurate.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3 SPINAL NEEDLES BY REGION 2021 & 2020 (USD MILLION)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe spinal needles market is expected to account for the second-largest market share due to increasing older population and rising patient population. Additionally, improving government initiatives and increasing healthcare reforms, and rising demand for technologically innovative treatment drive the growth of the spinal needles market in Europe. Further, the Germany spinal needles market is expected to hold the largest market share during the study period, and the UK spinal needles market is expected to fastest-growing market in the European region. Furthermore, Spain spinal needles market held the 5th place for the market share.

The Asia-Pacific spinal needles market is expected to grow at a healthy CAGR from 2024 to 2032. This is due to the due to the rising number of universities sponsoring clinical trials, increasing healthcare spending, multinational companies moving toward the developing nations, and setting operational set-ups are likely to drive the growth of the market, the region offers lucrative opportunities for players in the spinal needles market. Moreover, Japan’s spinal needles market is expected to hold the largest market share, and China spinal needles market is expected fastest-growing market in the Asia-Pacific region.

For instance, Japan’s spinal needles environment has been a significant transformation. Businesses engaged in spinal needles have a greater need to be aware of the fast-changing environment in order to benefit from the expansion, making it to be the world leader in the market for the spinal needles market.

The Middle East & Africa includes the Middle East, Africa. Nevertheless, due to a limited access and healthcare affordability among the population, particularly in Africa, the Middle East and Africa held the smallest proportion of the Spinal Needles Market.

Spinal Needles Key Market Players & Competitive Insights

The Spinal Needles Market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid technological advances, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.

The major players have adopted a strategy of obtaining regulatory approval from government agencies for their products and signing contracts and agreements to broaden their reach and reduce operational costs. In August 2020, B. Braun (Germany) received the US FDA approval for its Onvision ultrasound guidance needle tip tracking solution, aiming to drastically improve success rates in regional anesthesia procedures. In September 2019, B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution, which works in real-time for regional anesthesia processes. The Spinal Needles Market is extremely competitive, with players investing heavily in R&D to create product differentiation and gain a significant market share.

Key Companies in the Spinal Needles Market Include.

• Braun Melsungen AG (US)


• Stryker Corporation (US)


• Boston Scientific Corporation (US)


• Becton, Dickinson, and Company (US)


• Smith’s Medical (US)


• Myco Medical (US)


• Argon Medical (US)


• Exelint International, Co. (US)

Spinal Needles Industry Developments

December 2020 Smiths Medical (US) launched its Portex EchoGlo needle portfolio which work for echogenic brightness under ultrasound and are designed to make medication delivery more efficient and accurate. This further improves the companies pain management product portfolio.

September 2019 B. Braun (Germany) collaborated with Philips (Netherlands) to launch the Onvision needle tip tracking guidance solution which works in real-time for regional anaesthesia processes.  This works in line with Philip’s ultrasound system, making anaesthesia processes safer and more accurate.

January 2021 Stryker Corporation (US) acquired OrthoSensor, Inc. (US), a market leader in providing digital care in musculoskeletal care and total joint replacement sensor technology. The move will help the company innovate novel treatments, in the spinal segment as well.

December 2020 Argon Medical (US) acquired Mana-Tech, Ltd. (UK) which was its exclusive product distributor in the UK and Ireland. This move helped the company to expand its reach throughout Europe.

November 2020 Medtronic plc (Ireland) acquired Medicrea (France) to become the first company to provide Artificial Intelligence (AI) driven spinal surgery planning, implant, and robotic surgery with the help of Medicrea Ai capabilities.

Spinal Needles Market Segmentation

Spinal Needles Type Outlook

• Pencil-Point Needles


• Directional Spinal Needles


• Atraumatic Needles

Spinal Needles Application Outlook

• Therapeutic


• Diagnostic

Spinal Needles End User Outlook

• Hospitals & Clinics


• Diagnostic Centers


• Research Laboratories


• Speciality Centres

Spinal Needles Regional Outlook

• 
  

  North America

  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  

  Europe

  
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  

  Asia-Pacific

  
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  

  Middle East and Africa

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa